{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T10:01:36Z","timestamp":1708682496946},"reference-count":51,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":4045,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[1997,6]]},"abstract":"<jats:p>The present review outlines current management issues and controversies related to <jats:italic>Helicobacter pylori<\/jats:italic> infection. Clearance of this infection markedly reduces the likelihood of duodenal and gastric ulcer recurrence and may result in the regression of low grade primary gastric lymphoma. Recent therapeutic advances have seen the development of simpler drug regimens to treat <jats:italic>H. pylori<\/jats:italic> that have fewer side effects and are shorter in duration. Clearance of the infection can be achieved in 80\u201395% of patients treated, depending on the drug regimen used, compliance with medications and antibiotic sensitivity. In developed nations reinfection is uncommon after successful treatment. Data do not currently support treatment of this infection for non\u2010ulcer dyspepsia or for the prevention of gastric cancer, although whether certain individuals or populations may benefit from such treatment remains to be clarified.<\/jats:p>","DOI":"10.1111\/j.1440-1746.1997.tb00459.x","type":"journal-article","created":{"date-parts":[[2008,3,11]],"date-time":"2008-03-11T00:26:25Z","timestamp":1205195185000},"page":"419-424","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["R<scp>eview<\/scp>: <i>Helicobacter pylori.<\/i> Current issues and new directions"],"prefix":"10.1111","volume":"12","author":[{"given":"GEOFFREY M","family":"FORBES","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"1273","article-title":"Unidentified curved bacilli on gastric epithelium in active chronic gastritis","author":"Warren JR","year":"1983","journal-title":"Lancet"},{"key":"e_1_2_1_3_2","first-page":"65","article-title":"NIH Consensus Development Panel for Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease: NIH consensus conference","volume":"272","year":"1994","journal-title":"JAMA"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.1.1"},{"key":"e_1_2_1_5_2","first-page":"92","article-title":"Age related prevalence of Helicobacter pylori antibodies in Indian subjects","volume":"13","author":"Gill HH","year":"1994","journal-title":"Indian J. Gastroenterol."},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008469-199502000-00007"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.5694\/j.1326-5377.1988.tb120800.x","article-title":"The use of serology to diagnose active Campylobacter pylori infection","volume":"149","author":"Hazell HM","year":"1988","journal-title":"Med. J. Aust."},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91473-Y"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.12.1681"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91111-8"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510123331508"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91460-5"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199501193320302"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0950-3528(95)90047-0"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.155.18.1929"},{"key":"e_1_2_1_16_2","first-page":"203","article-title":"Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy","volume":"89","author":"Kim JG","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00361.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90665-8"},{"key":"e_1_2_1_19_2","first-page":"A79","article-title":"Does eradication of H. pylori prevent NSAID\u2010induced ulcers? A prospective randomised trial.","volume":"110","author":"Chan FKL","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_1_20_2","first-page":"A165","article-title":"Helicobacter pylori, NSAIDs and the risk of peptic ulcer bleeding: A prospective case\u2010control study with matched pairs.","volume":"110","author":"Labenz J","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90007-8"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91409-F"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a059184"},{"key":"e_1_2_1_24_2","volume-title":"Schistosomes, liver flukes and Helicobacter pylori: Views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"1994"},{"key":"e_1_2_1_25_2","first-page":"4731","article-title":"Gastric precancerous process in a high risk population: Cross\u2010sectional studies","volume":"50","author":"Correa P","year":"1990","journal-title":"Cancer Res."},{"key":"e_1_2_1_26_2","first-page":"4737","article-title":"Gastric precancerous process in a high risk population: Cohort follow\u2010up","volume":"50","author":"Correa P","year":"1990","journal-title":"Cancer Res."},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.33.8.711"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91034-0"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)01501-2"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0889-8553(21)00265-X","article-title":"Helicobacter pylori and gastric cancer","volume":"22","author":"Parsonnet J.","year":"1993","journal-title":"Gastroenterol. Clin. North Am."},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1996.tb00312.x"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1995.tb124563.x"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19901101)66:9<2047::AID-CNCR2820660934>3.0.CO;2-G"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920701)70:1<50::AID-CNCR2820700109>3.0.CO;2-I"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.1.12"},{"key":"e_1_2_1_36_2","first-page":"1401","article-title":"Increase of Helicobacter pylori associated corpus gastritis during acid suppressive therapy: Implications for long\u2010term safety","volume":"90","author":"Kuipers EJ","year":"1995","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604183341603"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90278-3"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1996.tb00078.x"},{"key":"e_1_2_1_40_2","first-page":"1138","article-title":"Do commercial serological kits for Helicobacter pylori infection differ in accuracy. A meta\u2010analysis","volume":"91","author":"Loy CT","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)93191-O"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.agast960302"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.70.829.809"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92340-3"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8536890"},{"key":"e_1_2_1_46_2","volume-title":"Helicobacter pylori Guidelines for Healthcare Providers","author":"Australian Gastroenterology Institute","year":"1995"},{"key":"e_1_2_1_47_2","first-page":"1716","article-title":"Metaanalysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori.","volume":"87","author":"Chiba N","year":"1992","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0950-3528(95)90050-0"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92962-2"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"issue":"2","key":"e_1_2_1_51_2","first-page":"A36","article-title":"High cure rates with ranitidine bismuth citrate (Pylorid) plus clarithromycin given twice daily.","volume":"39","author":"Bardham KD","year":"1996","journal-title":"Gut"},{"key":"e_1_2_1_52_2","first-page":"33","article-title":"Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori.","volume":"89","author":"Borody TJ","year":"1994","journal-title":"Am. J. Gastroenterol."}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.1997.tb00459.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.1997.tb00459.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T22:29:08Z","timestamp":1698445748000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.1997.tb00459.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,6]]}},"alternative-id":["10.1111\/j.1440-1746.1997.tb00459.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.1997.tb00459.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,6]]},"assertion":[{"value":"2008-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}